Event Date: Jun 21, 2023

Related Resources l Recording

Dementia is an umbrella term that is used to describe a group of related disorders associated with memory loss and other cognitive problems that affects an individual’s ability to function. 

We will discuss the approach to diagnosing dementia in the clinic setting including the major causes: Alzheimer’s disease, vascular cognitive impairment/dementia, dementia with Lewy bodies and frontotemporal dementia, and mixed dementia.

This integrated KTE webinar event is brought to you by brainXchange in partnership with the Alzheimer Society of Canada and the Canadian Consortium of Neurodegeneration in Aging (CCNA)



Sandra Black, OC, O.Ont., MD, FRCPC, FRSC, Senior scientist

Sandra E Black, O.C., O.Ont., Hon.DSc., MD, FRCP(C), FRSC, FANA, FAHA, FAAN, Professor of Medicine (Neurology) at Sunnybrook HSC, U Toronto, is an internationally known cognitive and stroke neurologist, actively engaged in > 70 pharma trials in the last 3 decades. She has published >650 peer publications (+70 invited) (Google HI 132; >70,00 citations) in a research career bridging dementia and stroke, using standardized, quantitative neuroimaging, cognitive, functional and neuropsychiatric measures, genetics, and neuropathology to study brain-behavior relationships in the common dementias, with a focus on inter- relationships of Small Vessel Disease and neurodegeneration Recognitions include Fellowship, Royal Society of Canada, UofT’s Faculty of Medicine Dean’s Lifetime Achievement Award, an Honorary Doctor of Science from the University of Waterloo, the Distinguished Achievement Award of AAN’s Society of Cognitive and Behavioural Neurology, UBC’s 2022 Margolese Brain Disorders prize, recognizing Canadians who have made outstanding contributions to amelioration and treatment of brain disorders and the AAIC’s Bill Thies Distinguished Service Award (2022). She was appointed Member of the Order of Ontario (2011) and Officer in the Order of Canada in 2015 for her contributions to Alzheimer’s disease, stroke and vascular dementia.  


Mario Masellis, MSc, MD, PhD, FRCPC, Clinician Scientist & Associate Professor, Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto

Dr. Mario Masellis obtained his MSc in Pharmacology from the University of Toronto in 1997, completed his medical training at the University of Toronto in 2001 and obtained his board certification (FRCP Canada) in Neurology since 2006. He has completed a clinical research fellowship in Cognitive & Movement Disorders Neurology in 2008 and obtained a PhD in Clinical Neurosciences in 2012. His clinical expertise is in the diagnosis and management of both Alzheimer’s and non-Alzheimer’s dementias, including Lewy body disorders, frontotemporal dementia, progressive supranuclear palsy and corticobasal syndrome. His research focuses on how genomic factors impact neuroimaging and cognitive phenotypes, and response to drugs in neurodegenerative diseases.